You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 6,043,279


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,043,279
Title: Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Abstract:Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
Inventor(s): Boehm; Marcus F. (San Diego, CA), Heyman; Richard A. (Encinitas, CA)
Assignee: Ligand Pharmaceuticals, Incorporated (San Diego, CA)
Application Number:08/799,396
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use; Process;

Drugs Protected by US Patent 6,043,279

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,043,279

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0637297 ⤷  Sign Up 01C0027 France ⤷  Sign Up
European Patent Office 0637297 ⤷  Sign Up SPC013/2001 Ireland ⤷  Sign Up
European Patent Office 0637297 ⤷  Sign Up CA 2001 00032 Denmark ⤷  Sign Up
European Patent Office 0637297 ⤷  Sign Up C300054 Netherlands ⤷  Sign Up
European Patent Office 0637297 ⤷  Sign Up SPC/GB01/041 United Kingdom ⤷  Sign Up
Austria 177733 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.